For the Inventor, By the Inventor

Enter assignee name

Baltimore, MD, United States of America

Guilford Pharmaceuticals, Inc.

USPTO Granted Patents = 98

EPO Patents = 1

Forward Citations = 1,799

Loading Chart...

Loading Chart...

61 inventors (with patents filed for the assignee):

Paul F Jackson (44 out of 45 patents)

Barbara S Slusher (44 out of 80 patents)

Keith M Maclin (27 out of 27 patents)

4. Jie Zhang (21 out of 37 patents)

5. Kevin L Tays (18 out of 18 patents)

6. Jia-He Li (16 out of 44 patents)

7. Takashi Tsukamoto (12 out of 22 patents)

8. Gregory S Hamilton (11 out of 97 patents)

9. Zhong Zhao (8 out of 16 patents)

10. Wenbin Dang (7 out of 12 patents)

11. Pavel Majer (6 out of 27 patents)

12. Doris Stoermer (6 out of 19 patents)

13. Joseph P Steiner (5 out of 64 patents)

14. James Perry English (5 out of 27 patents)

15. Eric Yanjun Wang (5 out of 24 patents)

Core Competencies:

NAALADase Inhibitors

Pharmaceutical Compositions

Poly(ADP-Ribose) Polymerase Inhibitors

Thiol-Based Compounds

Biodegradable Compositions

Solid Tumor Treatments

Cyclophilin Binding Compounds

Neural Tissue Damage

Ovarian Cancer Treatments

Rotamase Inhibitors

Anxiety Disorder Treatments

Gout Treatments

98 patents: Sort by Forward Citations

1. 7479535 - Phosphorous-containing compounds with polymeric chains, and methods of making and using the same (2009-01-20),

2. 7220780 - Naaladase inhibitors for treating retinal disorders and glaucoma (2007-05-22),

3. 7148250 - Indoles as NAALADase inhibitors (2006-12-12),

4. 7138543 - Thiolalkyl benzoic acid derivatives (2006-11-21),

5. 7125907 - Thiolactones (2006-10-24),

6. 7101568 - Methods and compositions for treating solid tumors (2006-09-05),

7. 6992215 - Thiol-based NAALADase inhibitors (2006-01-31),

8. 6887996 - Compounds and their use (2005-05-03),

9. 6884907 - Hydroxamic acids and acyl hydroxamines as naaladase inhibitors (2005-04-26),

10. 6852750 - Benzenedicarboxylic acid derivatives (2005-02-08),

11. 6812364 - Thiol-based NAALADase inhibitors (2004-11-02),

12. 6806261 - Methods for treating certain diseases using naaladase inhibitors (2004-10-19),

13. 6740777 - Thiolalkyl benzoic acid derivatives (2004-05-25),

14. 6723733 - Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses (2004-04-20),

15. 6716828 - Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage (2004-04-06),

Guilford Pharmaceuticals, Inc. is a pharmaceutical company specializing in the research, development, and commercialization of innovative medical treatments. With a strong focus on neurological disorders and oncology, Guilford Pharmaceuticals strives to improve the quality of life for patients around the world. Our team of experts is dedicated to delivering cutting-edge solutions that address unmet medical needs. Visit our website to learn more about our groundbreaking therapies and ongoing research initiatives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

98 Patents

#4 in Baltimore, MD

#33 in Maryland

#3,718 in US

#7,696 in the World

Baltimore, MD, United States of America

Guilford Pharmaceuticals, Inc.

Forward Citations = 1,799

61 inventors:

Paul F Jackson (44 out of 45 patents)

Barbara S Slusher (44 out of 80 patents)

Keith M Maclin (27 out of 27 patents)

4. Jie Zhang (21 out of 37 patents)

5. Kevin L Tays (18 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…